SENIOR LEADERS
高层领导
基本信息
- 批准号:8719239
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The senior leaders of the Consortium include sixteen individuals: The Director, the Deputy Director, ten Associate Directors, the Consortium Administrator, and three Deputy Associate Directors.
The Associate Directors provide oversight and coordination of the Consortium's scientific disciplines of basic sciences, clinical sciences, and public health sciences. They co-direct the oversight and coordination of various Consortium processes, including planning and evaluation, shared resources, membership, and allocation of developmental funds. In addition, they serve as institutional representatives. The three independent institutions in the Consortium have different cultures and locations, so these individuals have a strong communication role to ensure that the members within their institutions are aware of activities and issues of the Consortium. In addition to representing the interests of the Consortium at their institutions, they also represent the interests of their institutions within the Consortium.
The Deputy Associate Directors leaders are responsible for scientific planning for the Consortium, formation and management of the Consortium interdisciplinary goals for coordinating internal program review, shared resources review, and review of pilot funding. These functions are accomplished through their leadership of the Consortium Scientific Steering Committee, in which they enlist the help and support of the Consortium program leaders for these activities.
The Consortium Administrator is responsible for implementation of the Consortium goals and objectives, and coordination of Consortium and CCSG administrative and management support activities.
该财团的高级领导人包括16个人:董事,副主任,十个副董事,财团管理员和三名副董事。
副主任提供了对财团的基础科学,临床科学和公共卫生科学的科学学科的监督和协调。他们共同指导各种财团流程的监督和协调,包括计划和评估,共享资源,会员资格以及发展基金的分配。此外,它们是机构代表。财团中的三个独立机构具有不同的文化和地点,因此这些人具有强大的沟通作用,以确保其机构中的成员了解财团的活动和问题。除了代表其机构的财团利益外,它们还代表了财团内部机构的利益。
副副总监领导人负责协调内部计划审查,共享资源审查以及试点资金审查的联盟跨学科目标的科学规划。这些职能是通过他们的领导力联盟科学指导委员会来实现的,在该委员会中,他们为这些活动提供了联盟计划领导者的帮助和支持。
财团管理员负责实施财团的目标和目标,并协调联盟和CCSG行政和管理支持活动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
LELAND H HARTWELL的其他基金
Thermoscientific TSQ Vantage Mass Spectrometer
Thermoscientific TSQ Vantage 质谱仪
- 批准号:77920127792012
- 财政年份:2010
- 资助金额:$ 5万$ 5万
- 项目类别:
相似国自然基金
磁性功能微球在核酸快速提取及检测中的基础科学问题探究
- 批准号:52373131
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
极端高温环境流动沸腾技术的基础科学问题及关键材料研究
- 批准号:52333015
- 批准年份:2023
- 资助金额:230 万元
- 项目类别:重点项目
先进航空发动机中超临界态煤油燃烧过程中的基础科学问题研究
- 批准号:52336006
- 批准年份:2023
- 资助金额:230 万元
- 项目类别:重点项目
企业基础科学研究的动因、机制与经济效果研究
- 批准号:72302229
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
耐高温高电压SiC功率器件灌封材料的多性能协同中的基础科学问题研究
- 批准号:52272001
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
The Tisch Cancer Institute - Cancer Center Support Grant
蒂施癌症研究所 - 癌症中心支持补助金
- 批准号:97539669753966
- 财政年份:2015
- 资助金额:$ 5万$ 5万
- 项目类别:
The Tisch Cancer Institute - Cancer Center Support Grant
蒂施癌症研究所 - 癌症中心支持补助金
- 批准号:97578649757864
- 财政年份:2015
- 资助金额:$ 5万$ 5万
- 项目类别:
The Tisch Cancer Institute - Cancer Center Support Grant
蒂施癌症研究所 - 癌症中心支持补助金
- 批准号:99063189906318
- 财政年份:2015
- 资助金额:$ 5万$ 5万
- 项目类别: